Explore

Trendline Trendline
Compal Electronics Reports Q1 2026 Results: Stable Sales but Declining Profit

Compal Electronics Reports Q1 2026 Results: Stable Sales but Declining Profit

Compal Electronics Reports Q1 2026 Results: Stable Sales but Declining Profit
Trendline Trendline
Compal Electronics Reports Q1 2026 Results: Sales Growth Amid Profit Decline

Compal Electronics Reports Q1 2026 Results: Sales Growth Amid Profit Decline

Compal Electronics Reports Q1 2026 Results: Sales Growth Amid Profit Decline
Trendline Trendline
Worksport Reports Significant Revenue Growth and Strategic Expansion in Q1 2026

Worksport Reports Significant Revenue Growth and Strategic Expansion in Q1 2026

Worksport Reports Significant Revenue Growth and Strategic Expansion in Q1 2026
Trendline Trendline
Hydrofarm Holdings Group Reports Significant Decline in First Quarter 2026 Financial Results

Hydrofarm Holdings Group Reports Significant Decline in First Quarter 2026 Financial Results

Hydrofarm Holdings Group Reports Significant Decline in First Quarter 2026 Financial Results
Trendline Trendline
Edible Garden Reports 22.9% Revenue Growth in Q1 2026 Amid Retail Expansion

Edible Garden Reports 22.9% Revenue Growth in Q1 2026 Amid Retail Expansion

Edible Garden Reports 22.9% Revenue Growth in Q1 2026 Amid Retail Expansion
Trendline Trendline
Edible Garden Achieves 22.9% Revenue Growth in Q1 2026 Amid Retail Expansion

Edible Garden Achieves 22.9% Revenue Growth in Q1 2026 Amid Retail Expansion

Edible Garden Achieves 22.9% Revenue Growth in Q1 2026 Amid Retail Expansion
Trendline Trendline
Edible Garden Reports Significant Revenue Growth and Retail Expansion in Q1 2026

Edible Garden Reports Significant Revenue Growth and Retail Expansion in Q1 2026

Edible Garden Reports Significant Revenue Growth and Retail Expansion in Q1 2026
Trendline Trendline
Guided Therapeutics Reports Q1 2026 Financial Results with No Revenue

Guided Therapeutics Reports Q1 2026 Financial Results with No Revenue

Guided Therapeutics Reports Q1 2026 Financial Results with No Revenue
Trendline Trendline
Suncrete Reports 64% Revenue Increase in Q1 2026 Amid Strategic Expansion

Suncrete Reports 64% Revenue Increase in Q1 2026 Amid Strategic Expansion

Suncrete Reports 64% Revenue Increase in Q1 2026 Amid Strategic Expansion
Trendline Trendline
Guided Therapeutics Reports Q1 2026 Financial Results Amid Regulatory Progress

Guided Therapeutics Reports Q1 2026 Financial Results Amid Regulatory Progress

Guided Therapeutics Reports Q1 2026 Financial Results Amid Regulatory Progress
Trendline Trendline
Guided Therapeutics Inc Reports No Revenue and Increased Net Loss in Q1 2026

Guided Therapeutics Inc Reports No Revenue and Increased Net Loss in Q1 2026

Guided Therapeutics Inc Reports No Revenue and Increased Net Loss in Q1 2026
Trendline Trendline
Suncrete Reports Q1 2026 Earnings with Significant Revenue Growth and Strategic Acquisitions

Suncrete Reports Q1 2026 Earnings with Significant Revenue Growth and Strategic Acquisitions

Suncrete Reports Q1 2026 Earnings with Significant Revenue Growth and Strategic Acquisitions